BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Deloitte
UBS
Citi
US Department of Justice
Queensland Health
Novartis
Cipla
Boehringer Ingelheim
McKesson

Generated: January 22, 2018

DrugPatentWatch Database Preview

Erythromycin ethylsuccinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for erythromycin ethylsuccinate and what is the scope of erythromycin ethylsuccinate patent protection?

Erythromycin ethylsuccinate
is the generic ingredient in twelve branded drugs marketed by Arbor Pharms Llc, Ani Pharms Inc, Ross Labs, Pharmacia And Upjohn, Alpharma Us Pharms, Dista, Naska, Parke Davis, Pharmafair, Wyeth Ayerst, Arbor Pharms Inc, Barr, Mylan, and Alra, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and one drug master file entries for erythromycin ethylsuccinate. Four suppliers are listed for this compound.
Pharmacology for erythromycin ethylsuccinate
Medical Subject Heading (MeSH) Categories for erythromycin ethylsuccinate

US Patents and Regulatory Information for erythromycin ethylsuccinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Inc ERYPED erythromycin ethylsuccinate TABLET, CHEWABLE;ORAL 050297-003 Jul 5, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ross Labs PEDIAZOLE erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 050529-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate TABLET;ORAL 062847-001 Sep 14, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Arbor Pharms Llc PEDIAMYCIN erythromycin ethylsuccinate SUSPENSION;ORAL 062304-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Naska ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062674-001 Mar 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062559-001 Mar 15, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Arbor Pharms Llc E.E.S. 400 erythromycin ethylsuccinate SUSPENSION;ORAL 061639-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate GRANULE;ORAL 062305-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Arbor Pharms Llc ERYPED erythromycin ethylsuccinate GRANULE;ORAL 050207-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate TABLET, CHEWABLE;ORAL 062306-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Covington
UBS
Harvard Business School
Novartis
QuintilesIMS
Citi
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot